Security Snapshot

TANDEM DIABETES CARE INC - NOTE 1.500% 3/1 Institutional Ownership

CUSIP: 875372AD6

13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

13

Principal

$308,532,000

Price (% of par)

102.05%

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 3 signals
Principal change
-$9,392,000
Market value change
-$9,670,451
Number of holders
13
Issuer context 1 identity field
SEC-reported market price (% of par)
102.05%
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • 875372AD6 - TANDEM DIABETES CARE INC - NOTE 1.500% 3/1 is tracked under CUSIP 875372AD6.
  • 13 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 25 to 13 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $323,354,014 to $314,863,591.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 13 institutions filings for Q1 2026.

Open SEC Evidence

Security key

875372AD6

Latest holder period

Q1 2026

13F holders

13

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 13 institutional investors reported holding $308,532,000 in principal (par value) of TANDEM DIABETES CARE INC - NOTE 1.500% 3/1.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
5
Latest
Q1 2026
Rows shown
1-5 of 5
Period Principal Value Change Price (% of par) (Median) Investors
2026 Q1 $308,532,000 $314,863,591 -$9,670,451 102.05% 13
2025 Q4 $316,899,000 $323,354,014 +$45,641,248 101.94% 25
2025 Q3 $290,113,129 $281,007,135 +$2,189,620 87.44% 23
2025 Q2 $304,778,243 $314,358,910 +$5,315,727 96.45% 26
2025 Q1 $306,194,500 $289,141,373 +$281,217,173 94.25% 28
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .